Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 8,123.5% | 111.3% | 131.3% | 130.7% | 58.3% | 44.2% | 86.4% | 94.6% | 83.9% | 92.6% | 114.5% | 89.6% | 85.5% | 141.4% | 94.9% | 86.1% | 78.6% | 93.3% | 62.6% | 44.9% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 12.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Edwards Lifesciences Corporation have been 62.6% over the past three years, and 75.9% over the past five years.
As of today, Edwards Lifesciences Corporation's FCF to Net Income is 12.1%, which is lower than industry median of 79.0%. It indicates that Edwards Lifesciences Corporation's FCF to Net Income is Bad.